RxDoctor Payments Data

Crystal Cook, MD

Family Medicine · California, MONPI 1285897827

Payments from drug & device makers

$644in general payments, 2019–2025

Across 40 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$123
  • Novo Nordisk$90
  • Amgen$79
  • Pfizer$52
  • Biohaven Pharmaceuticals, Inc.$47
  • AbbVie$47
  • plus $207 from 8 others

What the payments were for

  • Food & beverage$61295%
  • Education$325%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$644 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$66,128
Medicare patients
310
Services billed
1,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin97$97,222
OzempicSemaglutide74$83,475
EliquisApixaban88$68,727
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$59,228
TrulicityDulaglutide37$53,715
XareltoRivaroxaban31$34,736
MounjaroTirzepatide24$27,684
Repatha SureclickEvolocumab28$23,291
RybelsusSemaglutide17$20,375
JanuviaSitagliptin Phosphate24$18,223
ShingrixVaricella-Zoster Ge/As01b/Pf51$11,334
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$10,516
AbrysvoRsv Vacc, Pref A And Pref B/Pf30$9,716
Emgality PenGalcanezumab-Gnlm12$8,528
TrintellixVortioxetine Hydrobromide12$7,819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$90$103,84991 claims
Boehringer IngelheimJardiance$33$97,22297 claims
GSKTrelegy Ellipta, Shingrix, Anoro Ellipta, Arexvy$44$85,810146 claims
Lilly USA, LLCTrulicity, Mounjaro$28$81,39961 claims
PfizerEliquis, Abrysvo$52$78,443118 claims
Johnson & JohnsonXarelto$24$34,73631 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$7,81912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in California

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →